Ron Muhlenkamp, whose fund has bounced back strong this year after a rough stretch and has now beaten 90% of funds in its class in the past decade, is high on high-quality technology and healthcare stocks.
According to Kiplinger’s, Muhlenkamp is high on tech firms like Hewlett-Packard and Cisco. He’s also made a bundle on IBM in recent months, and is now scaling back on that position, Kiplinger’s says.
In the healthcare sector, Muhlenkamp likes Pfizer and UnitedHealth Group. Despite fears of government intervention in the sector, Muhlenkamp says that the firms are key parts of the healthcare industry, and good buys, according to Kiplinger’s. “The last time you had the chance to buy drug companies this cheap was during HillaryCare” in the early 1990s, he said.